Product image of Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra) supplied by GNH India

Multibic

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra
Origin:
EU

Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra)

Sodium hydrogen carbonate, magnesium chloride hexahydrate, sodium chloride, calcium chloride dihydrate, the active ingredient in Multibic, is an electrolyte solution presented as a solution for injection for intravenous and haemodialysis use. It provides electrolytes and buffering capacity during haemodialysis to maintain acid‑base and electrolyte balance.

GNH India supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Manufacturer / TM Owner

Fresenius Medical Care Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Multibic is used as an electrolyte solution in the haemodialysis pathway to support fluid and electrolyte management.

  • Dialysis fluid for haemodialysis: provides necessary electrolytes and buffering to maintain patient acid‑base balance during treatment.
  • Intravenous electrolyte replacement: restores electrolyte concentrations in patients with deficits during acute care.
  • Acid‑base management in renal replacement therapy: helps correct metabolic acidosis during dialysis sessions.

How It Works

  • Multibic delivers sodium, magnesium, calcium and chloride ions together with bicarbonate, which together replenish extracellular electrolytes and provide buffering capacity. The bicarbonate component helps neutralize excess hydrogen ions, supporting acid‑base homeostasis, while the mineral ions maintain osmotic balance and cellular function during haemodialysis or intravenous electrolyte therapy.

Side Effects

Multibic may be associated with infusion‑related reactions and electrolyte disturbances.

Common Side Effects

  • Hypotension: transient drop in blood pressure during infusion.
  • Nausea: mild gastrointestinal discomfort.
  • Vomiting: occasional emesis post‑infusion.
  • Headache: mild to moderate headache.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous rise in serum potassium.
  • Metabolic alkalosis: excessive bicarbonate leading to high pH.
  • Anaphylactic reaction: rare severe allergic response.
  • Cardiac arrhythmia: caused by significant electrolyte imbalance.

Precautions & Warnings

When using Multibic, clinicians should observe several safety measures.

  • Baseline assessment: evaluate patient electrolyte levels before initiation.
  • Blood pressure monitoring: watch for hypotension during infusion.
  • Cardiac risk: adjust composition for patients with known cardiac disease.
  • Hypernatremia avoidance: do not use in patients with severe high sodium levels.
  • Aseptic technique: maintain sterility to prevent contamination.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Multibic can interact with other agents that affect electrolyte balance.

Major Interactions (Avoid)

  • High‑dose calcium supplements: may cause hypercalcemia.
  • Potassium‑sparing diuretics: increased risk of hyperkalemia.
  • Additional bicarbonate‑containing solutions: may precipitate metabolic alkalosis.

Moderate Interactions (Monitor Closely)

  • Nephrotoxic IV antibiotics: monitor renal function and electrolytes.
  • Blood transfusions: watch for shifts in electrolyte concentrations.
  • Concurrent insulin therapy: monitor potassium levels closely.

Frequently Asked Questions

Multibic is an electrolyte solution used as dialysis fluid during haemodialysis and as an intravenous electrolyte replacement to restore mineral balance and support acid‑base homeostasis in patients undergoing renal replacement therapy.

The formulation supplies sodium, magnesium, calcium, chloride ions and bicarbonate. These components replenish extracellular electrolytes, provide buffering capacity to neutralize excess hydrogen ions, and help maintain osmotic and acid‑base equilibrium during dialysis or IV therapy.

The prescribed dose of Multibic is determined by the treating physician based on the patient’s clinical condition, dialysis prescription, and electrolyte requirements. Dosage is individualized and not fixed.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Multibic contains a balanced mix of sodium, magnesium, calcium, chloride and bicarbonate, offering comprehensive electrolyte and buffering support. Compared with single‑component solutions, it provides a broader spectrum of ions, which can reduce the need for additional supplementation during haemodialysis.

Multibic should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations to maintain sterility and stability.

Multibic is administered intravenously, either as part of the haemodialysis circuit or as a direct IV infusion. Administration is performed by qualified healthcare professionals following aseptic technique and the prescribed infusion rate.

Serious risks include severe hyperkalemia, metabolic alkalosis, anaphylactic reactions, and cardiac arrhythmias caused by significant electrolyte disturbances. Continuous monitoring of electrolyte levels and patient vital signs is essential during treatment.

Multibic should be avoided in patients with known severe hypernatremia, uncontrolled hypercalcemia, or documented hypersensitivity to any of its components. Clinicians should also exercise caution in patients with unstable cardiac conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.